๐ Excited to share our latest research on metabolomic signatures of carfilzomib-related cardiotoxicity in multiple myeloma patients, highlighting our newly developed risk score! #CardioOncology#Research
Our study investigates the endothelial dysfunction in patients undergoing carfilzomib treatment, focusing on creating a predictive risk score for cardiovascular adverse events (CVAE). #EndothelialDysfunction
We found that lower levels of protective biomarker T-UDCA in patients who developed CVAE could indicate a predisposition to these adverse events. This finding was crucial in developing our risk score. #Biomarkers #CVAE
By analyzing post-baseline/baseline ratios of metabolites, we identified key differences in dihydroxybenzoate, GCDCA, and ferulic acid between CVAE and non-CVAE patients. These metabolites are integral to our risk score. #Metabolomics
Our risk score incorporates the levels of these metabolites, providing a quantifiable measure to predict the likelihood of CVAE in patients undergoing carfilzomib treatment. #RiskScore #PredictiveModeling
Dihydroxybenzoate, known for its cardioprotective properties, plays a significant role in our risk score, linking metabolomic changes to potential cardiovascular risks. #Cardioprotection
The risk score also considers the beneficial roles of T-UDCA, statins, and regular exercise in reducing CVAE, emphasizing the importance of preventive strategies in high-risk patients. #CardioHealth #PreventiveCare
By integrating these factors, our risk score offers a personalized approach to predicting and mitigating cardiovascular risks, enhancing patient care and outcomes. #PersonalizedMedicine #CardioOncology
Our research contributes to a better understanding of the mechanisms behind carfilzomib-related cardiotoxicity and provides a practical tool for clinicians to assess and manage these risks. #CancerTherapy #RiskAssessment
๐ Dive into the full study for a comprehensive look at our methodology, detailed findings, and the development of our risk score: https://t.co/Y6QZeCY3aH #ResearchPublication #Science
@LauraLoomer@Delta Insane they wouldnโt just deplane and rebook you. In what other industry would we tolerate this level of service? Next time, Iโll asking Roy SR for the PJ.
For everyone yelling at me that school taxes are exempt: here is Gov DeSantis confirming those taxes are NOT exempt in his proposal.
Eliminating school homestead property taxes will cost FL schools $8.6B
The super wealthy in Florida are keeping homes in New York City where they stay when they need medical care. Is medicine really that bad in Florida? And is that much better in NYC? https://t.co/Yq0AlKWWf0